In this issue:
Decision aid for surgical management of early breast cancer
Pertuzumab-trastuzumab ± chemotherapy then emtansine in HER2+ metastatic breast cancer
Trastuzumab deruxtecan in HER2+ breast cancer: brain metastasis vs. progressive extracranial disease
Neoadjuvant talazoparib in germline BRCA1/2-mutated, early-stage TNBC
QOL in men with breast cancer
CDK4/6 inhibitors vs. paclitaxel for advanced breast cancer with (impending) visceral crisis
ctDNA association with residual cancer burden after neoadjuvant chemotherapy in TNBC
Chatbot vs. in-person pretest genetic counselling in new breast cancer
Ex vivo sensitivity testing for neoadjuvant anthracyclines in breast cancer
BMI and survival in early breast cancer
Please login below to download this issue (PDF)